Tribulus
Food supplement declared in France, declaration No 2024-6-1112
Tribulus (Revogenix) is a food supplement declared in France. Status: retrait du marché annoncé pour le 10 March 2027. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Revogenix
- Food business operator placing the product on the market
- LABORATOIRE TERRAVITA
- Status
- Retrait du marché annoncé pour le 10 March 2027
- Form
- Gélule
- Daily dose
- 2 gélules
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous antidiabétiques, Sous traitement antihypertenseur
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
Declaration 142938, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retrait du marché annoncé pour le 10 March 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Tribulus terrestris L. | Fruit | Extrait sec hydroalcoolique | 2,000 mg |
Other ingredients
Gélule végétale, Farine de noix de coco
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Revogenix